AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
Business Trip
Intro
This chapter explores the critical FDA decision regarding MDMA-assisted therapy for PTSD and its implications for patients and the psychedelic industry. It highlights the advisory committee meeting where experts assessed the drug application from Lycos Therapeutics and discusses the influence of these committees on drug development in mental health.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode